Short-term lipopolysaccharide treatment leads to astrocyte activation in LRRK2 G2019S knock-in mice without loss of dopaminergic neurons

Abstract Background The G2019S mutation of LRRK2, which enhances kinase activity of the protein, confers a substantial risk of developing Parkinson’s disease (PD). However, the mutation demonstrates incomplete penetrance, suggesting the involvement of other genetic or environmental modulating factor...

Full description

Bibliographic Details
Published in:	BMC Neuroscience
Main Authors:	Hoang Kieu Chi Ngo, Akriti Srivastava, Hoang Le, Samuel J. Ayer, Grace F. Crotty, Michael A. Schwarzschild, Rachit Bakshi
Format:	Article
Language:	English
Published:	BMC 2025-03-01
Subjects:	Parkinson’s disease Dopaminergic neuronal loss LRRK2 G2019S Autophosphorylaton LPS
Online Access:	https://doi.org/10.1186/s12868-025-00939-7

Similar Items

Enhancement of D1 dopaminergic responses in aged LRRK2 G2019S knock-in mice
by: Daniela Mercatelli, et al.
Published: (2025-05-01)

(G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse
by: Jun-Shiao Chou, et al.
Published: (2014-08-01)

Dysregulated Wnt and NFAT signaling in a Parkinson’s disease LRRK2 G2019S knock-in model
by: Andrea Wetzel, et al.
Published: (2024-05-01)

Commentary on "Synaptic function is modulated by LRRK2 and glutamate release is increased in cortical neurons of G2019S LRRK2 knock-in mice" by Beccano-Kelly, Kuhlmann, Tatarnikov et. al.
by: Elena ePopugaeva, et al.
Published: (2014-10-01)

LRRK2 G2019S Promotes Colon Cancer Potentially via LRRK2–GSDMD Axis-Mediated Gut Inflammation
by: Yuhang Wang, et al.
Published: (2024-03-01)

Differential LRRK2 Signalling and Gene Expression in WT-LRRK2 and G2019S-LRRK2 Mouse Microglia Treated with Zymosan and MLi2
by: Iqra Nazish, et al.
Published: (2023-12-01)

Cell-autonomous role of leucine-rich repeat kinase in the protection of dopaminergic neuron survival
by: Jongkyun Kang, et al.
Published: (2024-06-01)

Effect of leucine-rich repeat kinase 2 (LRRK2) on protein synthesis
by: Hyejung Kim, et al.
Published: (2018-01-01)

CRISPR/Cas9 and piggyBac-mediated footprint-free LRRK2-G2019S knock-in reveals neuronal complexity phenotypes and α-Synuclein modulation in dopaminergic neurons
by: Xiaobing Qing, et al.
Published: (2017-10-01)

Dopamine Transporter, PhosphoSerine129 α-Synuclein and α-Synuclein Levels in Aged LRRK2 G2019S Knock-In and Knock-Out Mice
by: Chiara Domenicale, et al.
Published: (2022-04-01)

A LRRK2 GTP Binding Inhibitor, 68, Reduces LPS-Induced Signaling Events and TNF-α Release in Human Lymphoblasts
by: Tianxia Li, et al.
Published: (2021-02-01)

AGE-induced neuronal cell death is enhanced in G2019S LRRK2 mutation with increased RAGE expression
by: Hyun Jin Cho, et al.
Published: (2018-01-01)

Pharmacological rescue of impaired mitophagy in Parkinson’s disease-related LRRK2 G2019S knock-in mice
by: Francois Singh, et al.
Published: (2021-08-01)

Transcriptome signatures of human neural stem cells derived from LRRK2 gene therapeutic cells
by: Doyeong Kim, et al.
Published: (2025-04-01)

Assessment of Mitochondrial Gene Activity in Dopaminergic Neuron Cultures Derived from Induced Pluripotent Stem Cells Obtained from Parkinson's Disease Patients
by: Anna S. Vetchinova, et al.
Published: (2023-12-01)

Mutated LRRK2 induces a reactive phenotype and alters migration in human iPSC-derived pericyte-like cells
by: Sanni Peltonen, et al.
Published: (2024-11-01)

The LRRK2-G2019S mutation attenuates repair of brain injury partially by reducing the release of osteopontin-containing monocytic exosome-like vesicles
by: Jiawei An, et al.
Published: (2024-07-01)

Generalized dystonia without Parkinsonism in an LRRK2 carrier
by: Lola Díaz-Feliz, et al.
Published: (2022-01-01)

The cellular and extracellular proteomic signature of human dopaminergic neurons carrying the LRRK2 G2019S mutation
by: Felix Knab, et al.
Published: (2024-12-01)

LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β<sub>1-42</sub> Fibrils
by: Alice Filippini, et al.
Published: (2023-02-01)

LRRK2G2019S Gene Mutation Causes Skeletal Muscle Impairment in Animal Model of Parkinson's Disease
by: Yiying Hu, et al.
Published: (2024-12-01)

Evolución y tratamiento de la fase avanzada de una serie de pacientes con enfermedad de Parkinson LRRK2
by: G. Fernández-Pajarín, et al.
Published: (2023-06-01)

LRRK2 kinase activity is necessary for development and regeneration in Nematostella vectensis
by: Grace Holmes, et al.
Published: (2024-08-01)

Cryo-electron tomography reveals the microtubule-bound form of inactive LRRK2
by: Siyu Chen, et al.
Published: (2025-10-01)

Fbxl18 targets LRRK2 for proteasomal degradation and attenuates cell toxicity
by: Xiaodong Ding, et al.
Published: (2017-02-01)

Mitochondrial Dysfunction in Dopaminergic Neurons Derived from Patients with LRRK2- and SNCA-Associated Genetic Forms of Parkinson’s Disease
by: Anna S. Vetchinova, et al.
Published: (2023-10-01)

Neuronal Firing and Glutamatergic Synapses in the Substantia Nigra Pars Reticulata of LRRK2-G2019S Mice
by: Giacomo Sitzia, et al.
Published: (2022-11-01)

Age- and Sex-Dependent Behavioral and Neurochemical Alterations in hLRRK2-G2019S BAC Mice
by: Ning Yao, et al.
Published: (2022-12-01)

LRRK2 kinase activity regulates Parkinson’s disease-relevant lipids at the lysosome
by: Michael T. Maloney, et al.
Published: (2025-08-01)

LRRK2 Inhibition Mitigates the Neuroinflammation Caused by TLR2-Specific α-Synuclein and Alleviates Neuroinflammation-Derived Dopaminergic Neuronal Loss
by: Dong-Hwan Ho, et al.
Published: (2022-03-01)

Autophagy and LRRK2 in the Aging Brain
by: Federica Albanese, et al.
Published: (2019-12-01)

Aberrant Patterns of Sensory-Evoked Activity in the Olfactory Bulb of LRRK2 Knockout Mice
by: Andrea Maset, et al.
Published: (2021-11-01)

LRRK2 and Lipid Pathways: Implications for Parkinson’s Disease
by: Jasmin Galper, et al.
Published: (2022-10-01)

Role of LrrkA in the Control of Phagocytosis and Cell Motility in Dictyostelium discoideum
by: Romain Bodinier, et al.
Published: (2021-03-01)

Frequency of the LRRK2 G2019S mutation in late-onset sporadic patients with Parkinson’s disease
by: Hsin Fen Chien, et al.
Published: (2014-05-01)

LRRK2 Gly2019Ser Mutation Promotes ER Stress via Interacting with THBS1/TGF‐β1 in Parkinson's Disease
by: Longping Yao, et al.
Published: (2023-10-01)

LRRK2 G2019S, I2020T, R1441C GENE mutation analysis in patients with idiopathic Parkinsons in Turkey
by: Ahmet Adiguzel, et al.
Published: (2020-06-01)

Pathological Functions of LRRK2 in Parkinson’s Disease
by: Ga Ram Jeong, et al.
Published: (2020-11-01)

Astrocytes carrying LRRK2 G2019S exhibit increased levels of clusterin chaperone via miR-22-5p and reduced ability to take up α-synuclein fibrils
by: Alice Filippini, et al.
Published: (2025-05-01)

Editorial: LRRK2—Fifteen Years From Cloning to the Clinic
by: Hardy Rideout, et al.
Published: (2022-04-01)